MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qad.0000000000001066

Медицинская библиотека · AIDS (London, England) · 2016

Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling.

García-Otero Laura, López Marta, Gómez Olga, Goncé Ana, Bennasar Mar, Martínez Josep Maria, Valenzuela-Alcaraz Brenda, Rodriguez-López Mérida, Sitges Marta, Loncà Montserrat, Bijnens Bart, Crispi Fàtima, Gratacós Eduard

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To evaluate the cardiac structure and function of the fetuses of pregnant women with HIV infection on combined antiretroviral treatment (cART) and the HIV-related and nonrelated determinants of abnormal findings.

DESIGN

A prospective cohort study including 42-noninfected fetuses from HIV pregnant women on cART and 84 fetuses from non-HIV-infected women.

METHODS

Fetal echocardiography was performed at 26-32 weeks of pregnancy to assess cardiac structure and function. The impact of maternal and perinatal factors on fetal cardiac remodelling was evaluated by multivariate regression analysis.

RESULTS

Fetuses from HIV pregnant women on cART presented larger hearts and pericardial effusion together with thicker myocardial septal walls (mean 3.56 mm (SD 0.88) vs non-HIV mean 2.75 mm (SD 0.77); P = 0.002) and smaller left ventricular cavities (10.81 mm (SD 2.28) vs 12.3 mm (SD 2.54); P = 0.033). Fetuses from HIV women also presented signs of systolic (mitral systolic annular peak velocity 5.85 cm/s (SD 0.77) vs non-HIV 6.25 cm/s (SD 0.97); P = 0.007) and diastolic (isovolumic relaxation time 52 ms (SD 8.91) vs non-HIV 45 ms (SD 7.98); P < 0.001) dysfunction. In the multivariate analysis, maternal treatment with zidovudine was the only factor significantly associated with fetal cardiac changes (P = 0.014).

CONCLUSION

Fetuses from HIV-infected mothers on cART have cardiac remodelling and dysfunction, which might explain the cardiovascular changes described in childhood. Fetal cardiac remodelling was essentially associated with maternal treatment with zidovudine which challenges its use during pregnancy.

Для цитирования: García-Otero Laura, López Marta, Gómez Olga, Goncé Ana, Bennasar Mar, Martínez Josep Maria, Valenzuela-Alcaraz Brenda, Rodriguez-López Mérida, Sitges Marta, Loncà Montserrat, Bijnens Bart, Crispi Fàtima, Gratacós Eduard. Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling.. AIDS (London, England). 2016. DOI: 10.1097/qad.0000000000001066.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.